Safest Choice of Antihypertensive Regimen for Postpartum Hypertension — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Safest Choice of Antihypertensive Regimen for Postpartum Hypertension — Stella

Recruiting

Back to Postpartum Complication trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

United States

Loma Linda University Health, Loma Linda, California

Key details

Phase

Large-scale testing

Sponsor

Loma Linda University

Enrollment target

~500 participants

Started

May 2023

Primary completion

December 2027

Age range

18 Years and older

Sex

Female only

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov